Cite
MLA Citation
Jacques Cadranel et al.. “Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.” ERJ open research, vol. 4, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100171986880.0x000017